Transgene Reports Results from Clinical Study of TG4001 in Combination with Avelumab in Advanced HPV-Positive Cancers

information fournie par Boursorama CP •22/07/2020 à 16:31

- Exploratory Phase 1b/2 trial targeting a heterogeneous population of patients with HPV16-positive, recurrent and/or metastatic cancer whose disease has progressed after up to three lines of chemotherapy, reports promising clinical activity with the combination regimen.